Zobrazeno 1 - 10
of 46
pro vyhledávání: '"Paul Joly"'
Autor:
Payel Banerjee, Paul Joly, Luc Jouneau, Yan Jaszczyszyn, Mickaël Bourge, Pierre Affaticati, Jean-Pierre Levraud, Pierre Boudinot, Jean-Stéphane Joly
Publikováno v:
Cells, Vol 11, Iss 13, p 2016 (2022)
We studied cell recruitment following optic tectum (OT) injury in zebrafish (Danio rerio), which has a remarkable ability to regenerate many of its organs, including the brain. The OT is the largest dorsal layered structure in the zebrafish brain. In
Externí odkaz:
https://doaj.org/article/f6588c60a50f40858f9f0e62d44da258
Autor:
Denis Chatelain, Jean-Claude Mazière, Gilles Duverlie, Jean-Claude Barbare, Jean-Paul Joly, Jean-Marc Regimbeau, Corinne Godin, Nathalie Trouillet, Véronique Descamps, Eric Nguyen-Khac, Charles Sabbagh, Christophe Louandre, Catherine François, Zakaria Ezzoukhry, Antoine Galmiche
Proteins of the BCL2 family are key regulators of apoptosis. Their expression levels are frequently altered in cancers, enabling tumor cells to survive. To gain insight into the pathogenesis of hepatocellular carcinoma (HCC), we performed a comprehen
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::33c92745c33eeea235e392bb7d3c57ce
https://doi.org/10.1158/1541-7786.c.6542223.v1
https://doi.org/10.1158/1541-7786.c.6542223.v1
Autor:
Denis Chatelain, Jean-Claude Mazière, Gilles Duverlie, Jean-Claude Barbare, Jean-Paul Joly, Jean-Marc Regimbeau, Corinne Godin, Nathalie Trouillet, Véronique Descamps, Eric Nguyen-Khac, Charles Sabbagh, Christophe Louandre, Catherine François, Zakaria Ezzoukhry, Antoine Galmiche
Supplementary Figures S1-S6; Supplementary Materials and Methods; Supplementary Table S1.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::190905a9d5cbeb885d8071c221463250
https://doi.org/10.1158/1541-7786.22519005
https://doi.org/10.1158/1541-7786.22519005
Autor:
Julien Edeline, Satoshi Hirano, Aurélie Bertaut, Masaru Konishi, Meher Benabdelghani, Katsuhiko Uesaka, Jérôme Watelet, Masayuki Ohtsuka, Pascal Hammel, Yuji Kaneoka, Jean-Paul Joly, Masakazu Yamamoto, Laure Monard, Yoshiyasu Ambo, Christophe Louvet, Masahiko Ando, David Malka, Masato Nagino, Jean-Marc Phelip, Tomoki Ebata
Publikováno v:
European Journal of Cancer. 164:80-87
Although gemcitabine-based chemotherapy is the standard of care for advanced biliary tract cancers (BTCs), adjuvant phase III studies (BCAT in Japan, PRODIGE 12 in France) failed to show benefit, possibly owing to fewer patients (n = 225 and n = 194)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fe72cc64c5070de82c9bdbf98444288a
https://doi.org/10.1016/j.ejca.2022.01.009
https://doi.org/10.1016/j.ejca.2022.01.009
Autor:
Jean-Paul Joly, Eric Assenat, Veronique Guerin-Meyer, Aurélie Bertaut, Jean-Louis Jouve, Jérôme Watelet, Christelle De La Fouchardiere, Catherine Lombard-Bohas, Trevor Stanbury, Karim Boudjema, Eveline Boucher, Laetitia Fartoux, Jean-Marc Phelip, Pascal Hammel, Jean-François Seitz, Karine Bouhier-Leporrier, Jean-Emmanuel Kurtz, M. Benabdelghani, Isabelle Baumgaertner, David Malka, David Tougeron, Roger Faroux, Julien Edeline, Christophe Louvet
Publikováno v:
Journal of Clinical Oncology
Journal of Clinical Oncology, American Society of Clinical Oncology, 2019, 37 (8), pp.658-667. ⟨10.1200/JCO.18.00050⟩
Journal of Clinical Oncology, American Society of Clinical Oncology, 2019, 37 (8), pp.658-667. ⟨10.1200/JCO.18.00050⟩
PURPOSE No standard adjuvant treatment currently is recommended in localized biliary tract cancer (BTC) after surgical resection. We aimed to assess whether gemcitabine and oxaliplatin chemotherapy (GEMOX) would increase relapse-free survival (RFS) w
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c0be4c2f1e0b39ec3fe3e2e0119457bf
https://pubmed.ncbi.nlm.nih.gov/30707660
https://pubmed.ncbi.nlm.nih.gov/30707660
Autor:
Jean-Paul Joly, Denis Chatelain, Jean-Marc Regimbeau, Bruno Chauffert, Cyril Cosse, Christophe Attencourt, Charles Sabbagh
Publikováno v:
World Journal of Gastroenterology
AIM To analyze the homogeneity of pathologic response to preoperative chemotherapy (PRPC) after chemotherapy in patients with multiple liver metastases (LM). METHODS From September 2011 to August 2014, patients with at least two LM undergoing preoper
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::02bf697ff048fcb112e82b1c9e389b37
https://pubmed.ncbi.nlm.nih.gov/29259378
https://pubmed.ncbi.nlm.nih.gov/29259378
Autor:
Vincent Hautefeuille, Jean Paul Joly, Jean-Marc Regimbeau, Denis Chatelain, Céline Lobry, B. Tramier, Marie Brevet, David Fuks, Charlotte Mouly, Bruno Chauffert, Eric Nguyen-Khac
Publikováno v:
International Journal of Hepatology, Vol 2013 (2013)
International Journal of Hepatology
International Journal of Hepatology
Background and Aims.Chemotherapy of colorectal liver metastases can induce hepatotoxicity in noncancerous liver. We describe these lesions and assess risk factors and impacts on postresection morbidity and mortality in naive patients to chemotherapy
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::735b0de24af739f935e9450915bd2972
https://doi.org/10.1155/2013/314868
https://doi.org/10.1155/2013/314868
Autor:
Jean-Jacques Tuech, Jean-Paul Joly, Jean-Marc Regimbeau, Pierre Verhaeghe, Patrick Pessaux, Thierry Yzet, Olivier Brehant, Sushil Deshpande, Denis Chatelain, B. Lefebure, Frédéric Dumont, Jean-Pierre Arnaud, François Mauvais, David Fuks
Publikováno v:
International Journal of Colorectal Disease
International Journal of Colorectal Disease, Springer Verlag, 2008, 23 (5), pp.477-481. ⟨10.1007/s00384-007-0409-5⟩
International Journal of Colorectal Disease, Springer Verlag, 2008, 23 (5), pp.477-481. ⟨10.1007/s00384-007-0409-5⟩
International audience; Background Only few case series have been published about locally advanced carcinoma of the right colon invading the duodenum or pancreas (CRCDP). We report results of a retrospective study about this rare entity focusing on m
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::088f8eddea90b3cd36ecdf3fb8ed5916
https://doi.org/10.1007/s00384-007-0409-5
https://doi.org/10.1007/s00384-007-0409-5
Autor:
Mohamed Hebbar, Pierre Michel, Patricia Maes, Renata Péreira, Emilia Rad, Olivier Bouché, Thierry Conroy, Laurent Gasnault, Antoine Adenis, Frédéric Di Fiore, Nathalie Deligny, Jean-Paul Joly, Charles Fournier, Peggy Fournier, Claire Giraud
Publikováno v:
Oncology. 73:185-191
Objective: To identify easily available predictive factors of response to cetuximab-irinotecan in patients with irinotecan-refractory metastatic colorectal cancer. Methods: Retrospective analysis of patients treated with cetuximab (400 mg/m2 in week
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e614de1c6555cbe8b4578dc118a6102b
https://doi.org/10.1159/000127385
https://doi.org/10.1159/000127385
Autor:
Brice Robert, Laurent Dugue, Charles Sabbagh, Thierry Yzet, Fabien Le Roux, Jean-Marc Regimbeau, Jean-Paul Joly
Publikováno v:
Hepatobiliarypancreatic diseases international : HBPD INT. 14(5)
Mirizzi syndrome, a rare complication of gallstones, is defined by obstruction of the main bile duct. This obstruction may worsen and thus result in cholecystobiliary fistula. Surgical management of Mirizzi syndrome is complicated by the presence of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1a7ac24d31aed50e9be75429ab603a6c
https://pubmed.ncbi.nlm.nih.gov/26459732
https://pubmed.ncbi.nlm.nih.gov/26459732